U.S. allows increased Vyvanse production to help ADHD drug shortage
The U.S. Drug Enforcement Administration (DEA) has authorized a roughly 24 percent increase in production of Vyvanse to address a nationwide shortage of ADHD medications. The DEA approved the surge in production at the request of the Food and Drug Administration (FDA). According to the notice First reported Bloomberg NewsThe FDA's request was issued in […]